ArticleGastroenterology & hepatology2013
Quality improvement in inflammatory bowel disease.
Article in Gastroenterology & hepatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- ACG Clinical Guideline: Management of Crohn's Disease in Adults.The American journal of gastroenterology · 2018Guideline
- Patient outcomes and healthcare utilisation following implementation of an advanced therapy care pathway for inflammatory bowel disease: a multicentre, prospective quasi-experimental preimplementation/postimplementation study in the Netherlands.BMJ open gastroenterology · 2026Article
- Risk of avoidant/restrictive food intake disorders in patients with inflammatory bowel disease: a matched cross-sectional case-control study.Journal of Crohn's & colitis · 2026Article
- A Hybrid Markov-SPC Approach to Assess Cost Differences in Urgent Care Utilization Using Patient-Reported Data in Inflammatory Bowel Disease.The Permanente journal · 2024Article
- Improving outpatient care in adult inflammatory bowel disease: effect of implementation of a reminder checklist in the electronic health records (IBD-ERS)-a pilot study.BMJ open quality · 2023Article
- Chronic steroid use: An overlooked impact on patients with inflammatory bowel disease.JGH open : an open access journal of gastroenterology and hepatology · 2022Article
- Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes.Digestive diseases and sciences · 2021Article
- Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021Article
- Management of Crohn Disease: A Review.JAMA · 2021Review
- New Zealand National Audit of Outpatient Inflammatory Bowel Disease Standards of Care.Clinical and experimental gastroenterology · 2020Article
- Quality improvement in healthcare for patients with inflammatory bowel disease.Translational pediatrics · 2019Review
- Improving Quality in the Care of Patients with Inflammatory Bowel Diseases.Inflammatory bowel diseases · 2018Review
- Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.Inflammatory bowel diseases · 2017Review
- Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study.BMJ (Clinical research ed.) · 2017Article
- Value redefined for inflammatory bowel disease patients: a choice-based conjoint analysis of patients' preferences.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2017Article
- Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NETClinical and experimental gastroenterology · 2017Article
- Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists.Annals of gastroenterology · 2017Article
- Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Children Inflammatory Bowel Disease Network-A Joint Partnership of CIHR and the CH.I.L.D. Foundation.Canadian journal of gastroenterology & hepatology · 2017Article
- Variation in Care of Inflammatory Bowel Diseases Patients in Crohn's and Colitis Foundation of America Partners: Role of Gastroenterologist Practice Setting in Disease Outcomes and Quality Process Measures.Inflammatory bowel diseases · 2016Article
- Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study.Inflammatory bowel diseases · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic illnesses such as inflammatory bowel disease (IBD) present a unique opportunity to define and improve the quality of care. Processes of care can be complex, and outcomes of care may vary across different healthcare delivery settings. Patients with IBD are managed over long periods of time and often by the same physician within a single care delivery system. Both patients with Crohn's disease and ulcerative colitis have variable courses of disease progression that require changes in therapy over time. These factors necessitate multiple areas of potential assessment and improvement of processes and outcomes of care. A current initiative is the development of quality measures. The American Gastroenterological Association has developed accountability measures for the Physician Quality Reporting System, and the Crohn's and Colitis Foundation of America has developed a set of top 10 recommended processes and outcomes of measurement for high-quality care of patients with IBD. In addition, the pediatric ImproveCareNow collaborative network has collected improvement data from dozens of pediatric centers over the past 5 years and has demonstrated improvement in overall disease activity in their cohort through iterative quality improvement processes. Future directions for quality indicators for adults with IBD will involve implementation of quality-measure reporting, both for purposes of reimbursement as well as improvement of care. These strategies will need to be closely monitored to evaluate the effect of improvement programs on outcomes.
Indexed as
Identifiers
23943663PMC3740804What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.